6533b823fe1ef96bd127f701

RESEARCH PRODUCT

Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance.

Vicente Balanzá-martínezVicent Balanzá-martínezVasco Videira DiasAna Isabel CaritaSofia BrissosMaria Luísa Figueira

subject

AdultMalemedicine.medical_specialtyCross-sectional studyNeuropsychological TestsStatistics NonparametricQuality of lifeRecurrencemedicineHumansCognitive skillPsychiatryBiological PsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesAnalysis of VarianceCognitionMiddle Agedmedicine.diseasePsychiatry and Mental healthCross-Sectional StudiesSchizophreniaQuality of LifeSchizophreniaFemaleSchizophrenic PsychologySelf ReportVerbal memoryPsychologyCognition DisordersNeurocognitiveSocial AdjustmentClinical psychology

description

Abstract Purpose To investigate whether symptomatic remission relates to better outcomes in schizophrenia. Methods Seventy-six schizophrenia patients were assessed using measures of cross-sectional symptomatic remission, social functioning, subjective quality of life (QoL), and cognition. Results Most patients (53; 69.7%) were not in remission. Remitted patients presented significantly better social functioning, better self-reported QoL, insight, and lower levels of depressive symptoms. They also showed a non-significant trend for better executive function, processing speed and verbal memory. Conclusions Symptomatic remission may be a good indicator of better clinical status, social functioning and QoL, but not so much for cognitive functioning.

yearjournalcountryeditionlanguage
2011-02-12Schizophrenia research
10.1016/j.schres.2011.04.001https://pubmed.ncbi.nlm.nih.gov/21514793